Risk-Based Quality Management: Who Should Be in the Room and When While Assessing Risks During a Clinical Trial?

被引：0
|
作者：
Katz, Terry [1 ]
Petrizzo, Maryrose [2 ]
Novak, Kamila [3 ]
Mehra, Munish [4 ]
机构：
[1] Daiichi Sankyo Inc, 211 Mt Airy Rd, Basking Ridge, NJ 07920 USA
[2] Contego Med, Raleigh, NC USA
[3] KAN Consulting, Athens, Greece
[4] Tigermed, Gaithersburg, MD USA
来源：
THERAPEUTIC INNOVATION & REGULATORY SCIENCE | 2024年 / 58卷 / 01期
关键词：
D O I：
10.1007/s43441-023-00591-5
中图分类号：
R-058 [];
学科分类号：
摘要：
引用
收藏
页码：18 / 20
页数：3
相关论文
共 12 条
  • [1] Risk-Based Quality Management: Who Should Be in the Room and When While Assessing Risks During a Clinical Trial?
    Terry Katz
    Maryrose Petrizzo
    Kamila Novak
    Munish Mehra
    Therapeutic Innovation & Regulatory Science, 2024, 58 : 18 - 20
  • [2] Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical Trials
    Abigail Dirks
    Maria Florez
    Francois Torche
    Steve Young
    Brian Slizgi
    Kenneth Getz
    Therapeutic Innovation & Regulatory Science, 2024, 58 : 520 - 527
  • [3] Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical Trials
    Dirks, Abigail
    Florez, Maria
    Torche, Francois
    Young, Steve
    Slizgi, Brian
    Getz, Kenneth
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (03) : 520 - 527
  • [4] Adoption Maturity Model for Risk-based Quality Management (RBQM) in Clinical Trials
    Florez, Maria
    Dirks, Abigail
    Sullivan, Linda
    Young, Steve
    Getz, Kenneth
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2025,
  • [5] Survey of Risk-Based Quality Management Status and Establishment of Operational Model in Clinical Trials
    Kim, EunHee
    Lim, Chiyeon
    YONSEI MEDICAL JOURNAL, 2020, 61 (05) : 423 - 430
  • [6] Risk-Based Quality and Compliance Management in Clinical Trials with Combination Products in Changing Global Regulatory Environment
    Kaliaev, A. O.
    Malikova, M. A.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (04) : 803 - 813
  • [7] Risk-Based Quality and Compliance Management in Clinical Trials with Combination Products in Changing Global Regulatory Environment
    A. O. Kaliaev
    M. A. Malikova
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 803 - 813
  • [8] Risk-Based Quality and Safety Management in Clinical Trials with Combination Devices in Changing Global Regulatory Environment
    Malikova, M.
    Kaliaev, A.
    DRUG SAFETY, 2022, 45 (10) : 1267 - 1267
  • [9] Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical Trials (vol 58, 520, 2024)
    Dirks, Abigail
    Florez, Maria
    Torche, Francois
    Young, Steve
    Slizgi, Brian
    Getz, Kenneth
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (05) : 996 - 996
  • [10] A Retrospective Look at the Efficiency of 100% Source Data Verification And The Possibilities Presented By Risk-Based Quality Management In Increasing Monitoring Efficiency While Maintaining Good Data Quality
    van der Velden, Frank M. A.
    Goodale, Brianna M.
    van Willigen, Marcel
    Smets, Lotte
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 414 - 415
12